Type: Press Release

Jill Berger, Kristine Seymour and Jason Rose to Serve as WellDoc Advisors Columbia, Maryland, February 28, 2018 – WellDoc®, a leading digital therapeutic company, announced today that it has expanded its advisory team with experts in employer benefits, payer relations and healthcare information technology (IT). Jill Berger, Kristine Seymour and Jason Rose now serve as…

Columbia, Maryland, January 18, 2018 – WellDoc®, a leading digital therapeutic company, announced  today that John L. Brooks, III, a recognized life-sciences executive with more than 40 years of experience, will join the company’s team as a strategic advisor. “We’re pleased that John has chosen to work with us as an advisor,” said WellDoc President…

Solera Health will integrate the BlueStar® Digital Therapeutic, a diabetes management solution, into its national network of Diabetes Prevention Program providers Phoenix, AZ, and Columbia, MD, January 17, 2018 – ​Solera Health, an integrated benefit network, and WellDoc®, a leading digital therapeutic company, announced today that WellDoc’s BlueStar® digital therapeutic will join the Solera network…

Cambridge, MA, and Columbia, MD, January 9, 2018 – Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement aimed at combining Voluntis’ insulin titration technology with WellDoc’s extensive digital coaching platform to create a holistic digital diabetes management solution for patients, providers, health systems and health plans. Voluntis…

Columbia, Maryland, January 8, 2018 – WellDoc®, a leading digital health company, announced that two executives will present at key digital health conferences this week. President and CEO Kevin McRaith will give a corporate overview at the 2018 Digital Medicine and Medtech Showcase at Parc 55 in San Francisco on January 9, at 11:30 a.m….

Columbia, Maryland, January 4, 2018 – WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type 2 diabetes can translate into significant healthcare cost savings. Truven Health Analytics®, part of the IBM Watson Health™ business, conducted an analysis for WellDoc using…

Columbia, Maryland, November 13, 2017 – WellDoc®, a leading digital health company, announced today that IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar®, WellDoc’s FDA-cleared, proven digital therapeutic for people living with type 2  diabetes, the “top app” in the category of clinical diabetes treatment. The related report entitled, “The Growing Value of…

Columbia, Maryland, November 2, 2017 – WellDoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in panel discussions in the coming months at prominent diabetes and healthcare conferences. The list of events is as follows: Diabetes Technology Society (Bethesda, MD)…

Ms. Pickering Brings More Than Two Decades of Experience Working with Employers, Health Plans and Health Systems Columbia, Maryland, October 3, 2017 – WellDoc®, a leading digital health company, announced today the appointment of Laurel Pickering, president and CEO of Northeast Business Group on Health (NEBGH), as the Company’s new Chief Revenue Officer (CRO). Ms….

Co-authors selected as the 2017 fellows of American Association of Diabetes Educators Columbia, Maryland, August 28, 2017 – Digital health leader, WellDoc®, announced today that two of  its diabetes thought leaders and educators, Malinda Peeples, RN, MS, CDE, FAADE, and Janice MacLeod, MA, RD, CDE, LD, FAADE, co-authored an article published in the September 2017…